AI readiness in pharma: Getting the foundation right
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
BC Platforms and NTT Life Science Corporation form an exclusive collaboration to drive data-driven medicine and strengthen Real-World Data capabilities worldwide.
BC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.
BC Platforms secures CHF 20 million in new financing led by Jolt Capital to accelerate innovation and scale our healthcare data and analytics capabilities worldwide.